Edgewise Therapeutics, Inc. ($EWTX)
Filing Information
| Accession Number | 0001185829-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
397,659
Total Value
$785,042.06
P&L
+inf% (+$13,251,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 17,969 | $0.00 | $0.00 | 48,584 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 21,875 | $0.00 | $0.00 | 70,459 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 8,782 | $43.64 | $383,253.51 | 61,677 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 8,276 | $43.66 | $361,315.26 | 53,401 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 913 | $44.33 | $40,473.29 | 52,488 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 17,969 | $0.00 | $0.00 | 35,938 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Aug 12, 2026 | Exercise/Conversion | 21,875 | $0.00 | $0.00 | 65,625 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Aug 12, 2026 | Grant/Award | 100,000 | $0.00 | $0.00 | 100,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 12, 2026 | Grant/Award | 200,000 | $0.00 | $0.00 | 200,000 | Direct | โ | View Details |